Article
Hereditary haemorrhagic telangiectasia: a clinical and scientific review.
European journal of human genetics : EJHG - 1 Jul 2009
Govani Fatima S, Shovlin Claire L
Abstract excerpt
The autosomal-dominant trait hereditary haemorrhagic telangiectasia (HHT) affects 1 in 5-8000 people. Genes mutated in HHT (most commonly for endoglin or activin receptor-like kinase (ALK1)) encode proteins that modulate transforming growth factor (TGF)-beta superfamily signalling in vascular endothelial cells; mutations lead to the development of fragile telangiectatic vessels and arteriovenous malformations. In...
Topics
- Activin Receptors, Type II
- Antigens, CD
- Endoglin
- Hemorrhage
- Humans
- Mutation
- Receptors, Cell Surface
- Signal Transduction
- Telangiectasia, Hereditary Hemorrhagic
- Transforming Growth Factor beta
